Innate Immune Responses and Osteoarthritis

Area of Science:

• Immunology
• Rheumatology
• Gerontology

Background:

• Osteoarthritis (OA) is a prevalent, painful joint disease affecting 40% of adults over 70.
• Age is the strongest predictor of OA, with obesity being the primary preventable risk factor.
• Both aging and obesity are linked to abnormal innate immune responses contributing to OA progression.

Purpose of the Study:

• This review focuses on the role of innate immune inflammatory responses in osteoarthritis (OA) progression.
• The review examines how aging and obesity-associated immune changes contribute to OA pathogenesis.
• Investigating the mechanisms underlying OA progression driven by immune dysregulation.

Main Methods:

• Literature review of recent studies on OA pathogenesis.
• Analysis of the role of myeloid cells, macrophages, and Toll-like receptor 4 (TLR4) in OA.
• Examination of the interplay between aging, obesity, and immune responses in joint tissues.

Main Results:

• Aging-associated myeloid skewing and obesity-related myeloid activation increase innate immune responses in OA.
• Synovial hyperplasia and macrophage infiltration are key features of OA progression.
• Toll-like receptor 4 (TLR4)-induced responses and adipokines contribute to a cycle of joint destruction.

Conclusions:

• The interplay between aging, obesity, and innate immunity creates a cycle of inflammation and joint damage in OA.
• Understanding these immune mechanisms is crucial for developing targeted OA therapies.
• Targeting myeloid activation and TLR4 pathways may offer therapeutic strategies for OA.